Results 11 to 20 of about 4,036 (152)

Experimental re-evaluation of flunarizine as add-on antiepileptic therapy

Journal of Pharmacy and Bioallied Sciences, 2011
Background: Experimental studies have found several calcium channel blockers with anticonvulsant property. Flunarizine is one of the most potent calcium channel blockers, which has shown anticonvulsant effect against pentylenetetrazole (PTZ) and maximal ...
Anamika Thakur, A K Sahai, J S Thakur
doaj   +2 more sources

Flunarizine in Alternating Hemiplegia

Pediatric Neurology Briefs, 1988
The effects of flunarizine, a calcium-entry blocker, in alternating hemiplegia are reported in the first 12 children included in an international study coordinated from the Dept Pediatrics, University Hospital Gasthuisberg, B-3000 Leuven, Belgium.
J Gordon Millichap
doaj   +2 more sources

A postmarketing study of flunarizine in migraine and vertigo

, 1997
This prospective, open multi-centre study on flunarizine focused on the risk/benefit ratio of the use of flunarizine in the prophylaxis of migraine and in the treatment of vertigo, due to disorder of the vestibular system. The assessment of risks focused
Van Marwijk, Harm, de Bock, G H, Tromp, T P, Eelhart, J, Springer, M P   +4 more
core   +11 more sources

Vestibular Paroxysmia Coexisting With Meige Syndrome: A Case Report. [PDF]

Clin Case Rep
ABSTRACT VP and MS are distinct clinical entities arising from the peripheral vestibular system and central extrapyramidal pathways, respectively. We report a rare case of a 69‐year‐old woman with coexistence of VP and MS. Individualized pharmacotherapy resolved vertigo and markedly improved blepharospasm.
Ding Y, Yin G, Dai Y, Qin F, Zeng X, Huang Q, Li Y.   +6 more
europepmc   +2 more sources

Comparison of the effectiveness of first-line preventive treatment of migraine in primary care: study protocol for a pragmatic clinical trial (PREMI study) [PDF]

Trials
Background Migraine is a neurological disorder affecting approximately 12% of the population, more frequent in women, causing disability. Preventive treatment is recommended to prevent chronification and analgesics’ abuse and to improve quality of life ...
Maria Giner-Soriano, Rosa Morros, Ramon Monfà, Dan Ouchi, Silvia Fernández-García, Cristina Vedia, Sara Bonet Monné, Eva María Calvo Martínez, Silvia Copetti Fanlo, Noemí Morollón, Robert Belvís Nieto, Claudia Erika Delgado-Espinoza, Ana García-Sangenís   +12 more
doaj   +2 more sources

Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review. [PDF]

Mov Disord
Abstract Background The first International Parkinson and Movement Disorder Society Evidence‐Based Medicine (MDS‐EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was adopted by MDS, and new evidence exists.
Dash D, Bruno V, Schwingenschuh P, Lyons KE, Tan EK, Testa CM, Lloret SP, Balint B, Costa J, de Bie RMA, Silverdale MA, Tan AH, Mestre TA.   +12 more
europepmc   +2 more sources

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

The Journal of Headache and Pain, 2023
Objective Novel disease-specific and mechanism-based treatments sharing good evidence of efficacy for migraine have been recently marketed. However, reimbursement by insurers depends on treatment failure with classic anti-migraine drugs.
Christina I. Deligianni, Simona Sacco, Esme Ekizoglu, Derya Uluduz, Raquel Gil-Gouveia, Antoinette MaassenVanDenBrink, Raffaele Ornello, Margarita Sanchez-del-Rio, Uwe Reuter, Jan Versijpt, Tessa de Vries, Muizz Hussain, Dena Zeraatkar, Christian Lampl   +13 more
doaj   +1 more source

Exploring the Potential of Flunarizine for Cisplatin-Induced Painful Uremic Neuropathy in Rats [PDF]

International Neurourology Journal, 2011
Purpose The present study was designed to explore the potential of flunarizine for cisplatin induced painful uremic neuropathy in rats. Methods Cisplatin (2 mg/kg; i.p., for 5 consecutive days) was administered and renal uremic markers i.e., serum ...
Arunachalam Muthuraman, Sumeet Kumar Singla, Anil Peters   +2 more
doaj   +1 more source

A case of flunarizine-induced movement disorder

Journal of Indira Gandhi Institute of Medical Sciences, 2023
Flunarizine is a calcium channel antagonist widely used for the treatment of migraine. This can cause side effects like movement disorders with longstanding use in the elderly, especially females.
Anwar Alam, Baidyanath Kumar, Zeyaur Rahman Azad, C. Rajalakshmi   +3 more
doaj   +1 more source

Prophylactic treatments for vestibular migraine: a systematic review and network meta-analysis of randomized clinical trials

Frontiers in Pharmacology, 2023
Objectives: We compared and ranked the efficacy and tolerability of multiple prophylactic treatments for vestibular migraine (VM), including β-blockers, calcium channel blockers, antiseizure medications, and antidepressants such as tricyclics and ...
Hongyuan Chu, Hongyuan Chu, Yuru Wang, Xia Ling, Kangzhi Li, Xu Yang   +5 more
doaj   +1 more source